20 C
London
HomeTechnology

Technology

Realtor.com Acquisition of Zenlist Strengthens Agent-Client Collaboration Tools

Realtor.com Acquisition of Zenlist Marks Strategic Tech Expansion The Realtor.com acquisition of Zenlist represents a significant step in enhancing its technological capabilities within the competitive real estate market. By integrating Zenlist’s collaborative search tools, Realtor.com strengthens its commitment to providing agents and clients with a...

Linda Yaccarino investment X: A high‑stakes revival under scrutiny

Linda Yaccarino investment X moves into the spotlight as X reports its first year of ad revenue growth since Elon Musk’s acquisition. Yet controversy is simmering over alleged advertiser pressure from Yaccarino herself, claims she robustly denies. Meanwhile, a new “super‑app” strategy with X...

Olo acquired by Thoma Bravo: a $2 billion strategic shift for restaurant technology

The announcement that Olo acquired by Thoma Bravo marks a pivotal development in the restaurant technology landscape. Olo Inc. (NYSE: OLO), a prominent open SaaS platform serving leading restaurant brands, has entered into a definitive agreement to be acquired by Thoma Bravo, a private...

Accenture Acquisition of SYSTEMA Strengthens Manufacturing Automation for Semiconductor Clients

Accenture Acquisition of SYSTEMA marks a significant step in advancing manufacturing automation for semiconductor producers across Europe. The strategic purchase of SYSTEMA, a Dresden-based specialist in software solutions and consulting for industrial automation, will deepen Accenture’s ability to support the semiconductor and high-tech sectors. In...

Sheikh Tahnoon bin Zayed: The Strategic Mind Behind the UAE’s Executive AI

A silent builder at the helm of a technological empire In a world where AI is becoming the new center of power, media personalities abound. Behind the scenes, another force is emerging. Discreet, sovereign, and really effective. His name : HH Sheikh Tahnoon bin Zayed...

Klotho Neurosciences ALS Gene Therapy Progresses Toward Clinical Stage

Klotho Neurosciences ALS gene therapy KLTO-202 is advancing through a critical phase of manufacturing and process development, positioning the company for early-stage clinical trials by Q3 2026. This significant milestone reflects Klotho Neurosciences, Inc. (NASDAQ: KLTO)'s ongoing commitment to tackling amyotrophic lateral sclerosis (ALS),...